Collectively, these findings indicate that estrogens and estrogen-like compounds may exert pleiotropic actions through ERα in a direct manner, as well as via GPER–EGFR transduction signaling, which may engage ERα toward the stimulation of cancer cells. The gene discussed is EGFR; the disease is cancer.